KIAA0101 interacts with BRCA1 and regulates centrosome number

Molecular Cancer Research

Volumn 9, Issue 8, 2011, Pages 1091-1099

  Kais, Zeina ^a   Barsky, Sanford H ^c   Mathsyaraja, Haritha ^a   Zha, Alicia ^a   Ransburgh, Derek J R ^a,b   He, Gang ^a   Pilarski, Robert T ^a   Shapiro, Charles L ^a   Huang, Kun ^a,b   Parvin, Jeffrey D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; KI 67 ANTIGEN; PROTEIN KIAA 0101; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER TISSUE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CENTROSOME; DISEASE SEVERITY; GENE OVEREXPRESSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR GROWTH;

ANTIGENS, CD44; BRCA1 PROTEIN; BREAST NEOPLASMS; CARRIER PROTEINS; CENTROSOME; DNA DAMAGE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HELA CELLS; HOMOLOGOUS RECOMBINATION; HUMANS; KI-67 ANTIGEN; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 80051973836     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0503     Document Type: Article

References (39)

1. Serova O.M., Mazoyer S., Puget N., Dubois V., Tonin P., Shugart Y.Y., et al. Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Am J Hum Genet 1997;60:486-495 (Pubitemid 27097596)
2. Thompson D., Szabo C.I., Mangion J., Oldenburg R.A., Odefrey F., Seal S., et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A 2002;99:827-831 (Pubitemid 34106595)
3. Mangia A., Chiarappa P., Tommasi S., Chiriatti A., Petroni S., Schittulli F., et al. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers. Cancer Genet Cytogenet 2008;182:75-83. (Pubitemid 351491324)
4. Oldenburg R.A., Meijers-Heijboer H., Cornelisse C.J., Devilee P. Genetic susceptibility for breast cancer: How many more genes to be found? Crit Rev Oncol Hematol 2007;63:125-149 (Pubitemid 46990913)
5. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007;39:1338-1349 (Pubitemid 350035000)
6. Starita L.M., Machida Y., Sankaran S., Elias J.E., Griffin K., Schlegel B.P., et al. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004;24:8457-8466 (Pubitemid 39245068)
7. Lingle W.L., Lutz W.H., Ingle J.N., Maihle N.J., Salisbury J.L. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity. Proc Natl Acad Sci U S A 1998;95:2950-2955 (Pubitemid 28135835)
8. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998;58:3974-3985 (Pubitemid 28405657)
9. Nigg E.A. Centrosome aberrations: Cause or consequence of cancer progression? Nat Rev Cancer 2002;2:815-825 (Pubitemid 37328900)
10. Ko M.J., Murata K., Hwang D.S., Parvin J.D. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle. Oncogene 2006;25:298-303. (Pubitemid 43083691)
11. Sankaran S., Starita L.M., Groen A.C., Ko M.J., Parvin J.D. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005;25:8656-8668 (Pubitemid 41369184)
12. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., et al. ONCOMINE: A cancer microarray database and integrated datamining platform. Neoplasia 2004;6:1-6. (Pubitemid 38391943)
13. D'Assoro A.B., Stivala F., Barrett S., Ferrigno G., Salisbury J.L. GFPcentrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7. Ital J Anat Embryol 2001;106 Suppl 1:103-110
14. Ransburgh D.J., Chiba N., Ishioka C., Toland A.E., Parvin J.D. Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. Cancer Res 2010;70:988-995
15. Pierce A.J., Hu P., Han M., Ellis N., Jasin M. Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells. Genes Dev 2001;15:3237-3242 (Pubitemid 34008189)
16. Schlegel B.P., Starita L.M., Parvin J.D. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene 2003;22:983-991 (Pubitemid 36313142)
17. Agrawal H. Extreme self-organization in networks constructed from gene expression data. Phys Rev Lett 2002;89:268702.
18. Jansen R., Greenbaum D., Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res 2002;12:37-46. (Pubitemid 34065588)
19. Jansen R., Yu H., Greenbaum D., Kluger Y., Krogan N.J., Chung S., et al. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science 2003;302:449-453 (Pubitemid 37296271)
20. Tornow S., Mewes H.W. Functional modules by relating protein interaction networks and gene expression. Nucleic Acids Res 2003;31:6283-6289 (Pubitemid 37442357)
21. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., et al. NCBI GEO: Mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res 2007;35:D760-D765 (Pubitemid 46056306)
22. Collado M., Garcia V., Garcia J.M., Alonso I., Lombardia L., Diaz-Uriarte R., et al. Genomic profiling of circulating plasma RNA for the analysis of cancer. Clin Chem 2007;53:1860-1863 (Pubitemid 47509683)
23. Yuan R.H., Jeng Y.M., Pan H.W., Hu F.C., Lai P.L., Lee P.H., et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2007;13:5368-5376
24. Simpson F., Lammerts van Bueren K., Butterfield N., Bennetts J.S., Bowles J., Adolphe C., et al. The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res 2006;312:73-85. (Pubitemid 41668593)
25. Turchi L., Fareh M., Aberdam E., Kitajima S., Simpson F., Wicking C., et al. ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ 2009;16:728-737
26. Kuriyama R., Borisy G.G. Centriole cycle in Chinese hamster ovary cells as determined by whole-mount electron microscopy. J Cell Biol 1981;91:814-821 (Pubitemid 12211170)
27. Tsou M.F., Stearns T. Mechanism limiting centrosome duplication to once per cell cycle. Nature 2006;442:947-951 (Pubitemid 44285953)
28. Yu P., Huang B., Shen M., Lau C., Chan E., Michel J., et al. p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 2001;20:484-489 (Pubitemid 32158228)
29. Hosokawa M., Takehara A., Matsuda K., Eguchi H., Ohigashi H., Ishikawa O., et al. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res 2007;67:2568-2576 (Pubitemid 46548942)
30. De Azambuja E., Cardoso F., De Castro G. Jr, Colozza M., Mano M.S., Durbecq V., et al. Ki-67 as prognostic marker in early breast cancer: A meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007;96:1504-1513 (Pubitemid 46762956)
31. Van de Vijver M.J., He Y.D., Van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009. (Pubitemid 35461656)
32. Guo M., Li J., Wan D., Gu J. KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma. BMC Cancer 2006;6:109.
33. Fukasawa K., Choi T., Kuriyama R., Rulong S., Vande Woude G.F. Abnormal centrosome amplification in the absence of p53. Science 1996;271:1744-1747 (Pubitemid 26102826)
34. Griffin C.S., Simpson P.J., Wilson C.R., Thacker J. Mammalian recombination- repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol 2000;2:757-761
35. Kanai M., Tong W.M., Sugihara E., Wang Z.Q., Fukasawa K., Miwa M. Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl) ation in regulation of centrosome function. Mol Cell Biol 2003;23:2451-2462 (Pubitemid 36351026)
36. Kraakman-van der Zwet M., Overkamp W.J., Van Lange R.E., Essers J., Van Duijn-Goedhart A., Wiggers I., et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol Cell Biol 2002;22:669-679
37. Tutt A., Gabriel A., Bertwistle D., Connor F., Paterson H., Peacock J., et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 1999;9:1107-1110 (Pubitemid 29504480)
38. Yamaguchi-Iwai Y., Sonoda E., Sasaki M.S., Morrison C., Haraguchi T., Hiraoka Y., et al. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J 1999;18:6619-29.
39. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536